Clinical trials
Phase 1 trials in Pakistan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
152 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2012 | 2 |
| 2013 | 2 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 5 |
| 2019 | 4 |
| 2020 | 14 |
| 2021 | 18 |
| 2022 | 28 |
| 2023 | 14 |
| 2024 | 19 |
| 2025 | 26 |
| 2026 | 14 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 87 |
| Unknown status | 29 |
| Recruiting | 19 |
| Not yet recruiting | 8 |
| Active, not recruiting | 7 |
| Enrolling by invitation | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Combined Military Hospital Abbottabad | 17 |
| University of Karachi | 7 |
| Liaquat National Hospital & Medical College | 6 |
| Dow University of Health Sciences | 5 |
| Jinnah Postgraduate Medical Centre | 5 |
| Lahore General Hospital | 5 |
| Armed Forces Institute of Dentistry, Pakistan | 4 |
| King Edward Medical University | 4 |
| Aga Khan University | 3 |
| Armed Forces Hospital, Pakistan | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Postoperative Pain | 10 |
| Agnosia | 6 |
| Pain | 6 |
| Polycystic Ovary Syndrome | 5 |
| Vitiligo | 5 |
| Diabetes Mellitus | 4 |
| Melanosis | 4 |
| COVID-19 | 3 |
| Psychotic Disorders | 3 |
| Scabies | 3 |
Trials
Showing 26 to 50 of 152. Each trial links to its page on Pharma Observatory.
52 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.